Quick Answer
Regen BioPharma Inc reported Total Assets of $274.6 thousand for fiscal year 2025.
Regen BioPharma Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $274.6K | +70.5% |
| 2024 | $161.1K | -54.4% |
| 2023 | $353.6K | -36.7% |
| 2022 | $559.0K | -53.9% |
| 2021 | $1.21M | +883.9% |
| 2020 | $123.2K | +24.3% |
| 2019 | $99.1K | -52.6% |
| 2018 | $209.0K | -77.9% |
| 2017 | $944.2K | +195.7% |
| 2016 | $319.4K | +44.9% |
| 2015 | $220.5K | +1969.0% |
| 2014 | $10.7K | -90.8% |
| 2013 | $115.9K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $237.1K | +23.9% | -13.7% |
| September 30, 2025 | $274.6K | +70.5% | +39.5% |
| June 30, 2025 | $196.8K | +15.7% | +16.1% |
| March 31, 2025 | $169.5K | +20.4% | -11.5% |
| December 31, 2024 | $191.4K | +20.0% | +18.8% |
| September 30, 2024 | $161.1K | -54.4% | -5.3% |
| June 30, 2024 | $170.2K | -40.3% | +20.9% |
| March 31, 2024 | $140.8K | -65.4% | -11.8% |
- Regen BioPharma Inc showed an increase of +70.5% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Regen BioPharma Inc’s total assets has grown by 136.9% (from $115.9 thousand to $274.6 thousand).
- The most recent figure is from Regen BioPharma Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: